Bittium Launches Bittium Tough Mobile™ 2 C Smartphone Designed for CONFIDENTIAL Communications for Authorities
Bittium, the provider of the world’s most secure smartphone-based communication systems, launches Bittium Tough Mobile™ 2 C smartphone designed for CONFIDENTIAL communications for authorities. Smartphone's unique HW security solutions and multilayered security structure based on the hardened Android™ 9 operating system are reinforced with the dual-boot functionality, running two completely separate and hardened operating systems on a single platform: Confidential and Personal.
They cover 240 kilometers a day and share the streets with pedestrians, lorries, bicycles and cars. They control the traffic lights, communicate with their surroundings... but when you see them you won’t see anyone driving them. These autonomous vehicles are called AGV (automated guided vehicles) and drive around outside the workshops of the SEAT plant in Martorell.
89 startups from across Europe of which 14 are based in Scandinavia are selected for support to accelerate the development of promising health solutions.
Headstart is set up to help startups getting closer to market, receive clinical verification, evaluate patient need and benefit of their product or service as well as attracting further private investment. Through EIT Health’s network, the companies will make valuable contacts within EIT Health’s innovation ecosystem and will receive financial support of up to €50 000 each.
Recipo opens its own recycling plant and manufactures recycled plastic to be used in new electronic products
Recipo launched Recipo Material, a purpose-built recycling plant for plastic from electronic waste in Riga, Latvia. In association with their members, Recipo continues to set an example by providing a viable European recycling solution for plastic. As the leading Producer Responsibility Partner for electronics in the Nordic region, Recipo is the first collection scheme in the world to pioneer their own recycling plant.
Airbus and Koniku Inc. have made a significant step forward in the co-development of a solution for aircraft and airport security operations, by extending research activities to include biological hazard detection capabilities, as well as chemical and explosive threats.
The disruptive biotechnology solution, which was originally focused on the contactless and automated detection, tracking and location of chemicals and explosives on-board aircraft and in airports, is now being adapted, in light of the COVID-19 crisis, to include the identification of biological hazards.
Three leading European Air Forces have deployed single patient isolation pods to rescue covid-19 patients from remote areas. In record time, the EpiShuttle is now in service with The British Royal Air Force, The Royal Norwegian Air Force, the Royal Danish Air Force and the German Air Ambulance DRF.
The use of single patient isolation systems increase the efficiency of our healthcare system during the pandemic outbreak.
The coronavirus (COVID-19) pandemic presents unprecedented health, social and economic challenges for Europe, and has profound implications for the way people live and work across the globe. One of the changes that it is already having is the proportion of people working from home, as governments put in place social distancing and isolation measures. Eurofound research shows which countries already had the highest rates of people doing telework, or ICT-based mobile work, in Europe.
HUAWEI CLOUD Launches AI-Assisted Diagnosis for COVID-19, Outputting CT Quantification Results in Seconds
In the face of the COVID-19 epidemic, the National Health Commission of China has included CT features of COVID-19 as the clinical diagnosis standard for COVID-19 in Hubei Province in its official diagnosis and treatment solution released on February 4, 2020. As one of the decision-making methods for COVID-19 diagnosis and treatment, CT powers fast and effective diagnosis and evaluation. However, due to large numbers of lesions in lungs and rapid changes, multiple rechecks and image reviews are required in a short period of time, significantly increasing the workloads of imaging doctors.
The biopharma company Medicago successfully produced Virus-Like Particles (VLP) of the coronavirus in just 20 days using proprietary plant-based technology Medicago’s platform can produce both vaccine and antibody candidates against COVID-19 disease.
Medicago, a biopharmaceutical company headquartered in Quebec City, announced today that they have successfully produced a Virus-Like Particle (VLP) of the coronavirus just 20 days after obtaining the SARS-CoV-2 (virus causing the COVID-19 disease) gene.
Copyright © 2021. All rights reserved